"The model was trained on only a few thousand antibody sequences, out of the nearly 100 million protein sequences it learnt from. Despite this, a surprisingly high proportion of the model’s suggestions boosted the ability of antibodies against SARS-CoV-2, ebolavirus and influenza to bind to their targets."

https://www.nature.com/articles/d41586-023-01516-w?utm_source=Nature+Briefing&utm_campaign=78edf4fac2-briefing-dy-20230509&utm_medium=email&utm_term=0_c9dfd39373-78edf4fac2-42705947